Followers | 105 |
Posts | 20514 |
Boards Moderated | 1 |
Alias Born | 06/30/2012 |
Tuesday, April 15, 2014 10:04:36 PM
I am (and have always been) in the camp that they will be acquired close too or right after they receive FDA approval.
The more I analyze what would be in the shareholders' best interest, though, I keep coming up with a Partnership arrangement with a deep-pocketed provider. The industry knowledge and financial backing that a J&J or a Stryker could bring to the table would do wonders ! I could easily see TITXF stock going to 100+ if this were the case. So, even if it was a 51/49 type of arrangement to start with - this would still be the better move IMO to increase shareholder value vs. getting taken out just below...say $30.
* I hope Mgt. considers this as an option or, at the very least, holds out for a proper price based on in-depth FV calculations.
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM